Latest Prostate biopsy Stories
Tuning in to tune out may be just what's needed for men undergoing a prostate biopsy.
In a study of complication rates following prostate biopsy among Medicare beneficiaries, Johns Hopkins researchers have found a significant rise in serious complications requiring hospitalization.
Innovative alternative diagnosis options to prostate biopsy (MRI-S) and prostate cancer treatment (HIFU) are now being offered by Atlantic HIFU, a leader in quality prostate health care.
A man's rising PSA (prostate-specific antigen) level over several years â€“ which had been seen as a possible warning sign of prostate cancer â€“ has recently come under fire as a screening test because it sometimes prompts biopsies that turn out to be normal.
GRASS VALLEY, Calif., Feb.
In the February 2011 issue of European Urology, Jean-Nicolas Cornu and colleagues reported the evaluation of the efficacy of prostate cancer (PCa) detection by trained dogs on human urine samples.
SAN DIEGO, Sept.
NYON, Switzerland, September 15, 2010 /PRNewswire/ -- - Site Provides Information on New Blood Test and Unique Index to Help Reduce Unnecessary Biopsies ProstateHealthIndex.org - a major online resource to help assess risk for prostate cancer - is now available in five languages, English, French German, Italian and Spanish. Created by the scientific team behind the world's largest independent medical diagnostics company - Beckman Coulter, Inc.
New Mayo Clinic research studied the association between prostate-specific antigen (PSA) levels and prostate size and found that routine annual evaluation of prostate growth is not necessarily a predictor for the development of prostate cancer.
WESTMONT, Ill., Nov. 9 /PRNewswire/ -- Prostate cancer is the second most common cancer in American men. One in six men will be diagnosed during his lifetime, according to the American Cancer Society.
- The governor of a province or people.